Wire Stories
European Commission Approves Celltrion Healthcare�s Vegzelma� (CT-P16, biosimilar bevacizumab) for the Treatment of Multiple Types of Cancer
Vegzelma� offers European patients living with certain types of breast, lung, renal, colon, rectum, ovarian and cervical cancers a new, safe, and...